IntronA
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IntronA, covering 2010-10-13 to 2022-12-15. Get the full timeline:
Most recent: EMA Withdrawn: IntronA (interferon alfa-2b) — Merck Sharp & Dohme B.V.